Ventas, Inc. $VTR Shares Sold by Prestige Wealth Management Group LLC

Prestige Wealth Management Group LLC decreased its position in shares of Ventas, Inc. (NYSE:VTR) by 93.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the real estate investment trust’s stock after selling 6,296 shares during the quarter. Prestige Wealth Management Group LLC’s holdings in Ventas were worth $32,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in VTR. NewEdge Advisors LLC grew its stake in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares during the period. Empowered Funds LLC grew its stake in shares of Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after purchasing an additional 536 shares during the period. Woodline Partners LP grew its stake in shares of Ventas by 46.8% during the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after purchasing an additional 11,739 shares during the period. Focus Partners Wealth grew its stake in shares of Ventas by 130.4% during the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after purchasing an additional 12,233 shares during the period. Finally, Gamco Investors INC. ET AL acquired a new stake in shares of Ventas during the 2nd quarter worth approximately $805,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Trading Up 3.8%

Shares of VTR opened at $82.13 on Friday. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $91.06. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm’s fifty day moving average is $85.05 and its two-hundred day moving average is $82.36. The stock has a market cap of $39.93 billion, a PE ratio of 149.33, a price-to-earnings-growth ratio of 1.75 and a beta of 0.71.

Ventas (NYSE:VTR) last announced its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm earned $0.84 EPS. The company’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s payout ratio is 378.18%.

Analysts Set New Price Targets

VTR has been the topic of a number of analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Wells Fargo & Company raised their price objective on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings reissued a “buy (b-)” rating on shares of Ventas in a research note on Friday, March 27th. Jefferies Financial Group lifted their price target on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, Scotiabank lifted their price target on shares of Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $95.19.

Insider Buying and Selling at Ventas

In other news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the transaction, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.53% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.